Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT1 | P54687 | 13/20 | 0.42 |
| ▸ | BCAT2 | O15382 | 11/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
| ▸ | TNF | P01375 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HSPA1A | P0DMV8 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7927759 | 1.00 | BCAT1 (0.42) | BCAT1BCAT2SMN1; SMN2ALDH1A1CYP2C9 | |
| SCHEMBL7930378 | 0.85 | BCAT1 (0.42) | BCAT1BCAT2SMN1; SMN2ALDH1A1TSHR | |
| SCHEMBL7930382 | 0.85 | BCAT1 (0.42) | BCAT1BCAT2SMN1; SMN2ALDH1A1TSHR | |
| SCHEMBL9274567 | 0.79 | TDP1 (0.50) | BCAT1BCAT2SMN1; SMN2ALDH1A1CYP2C9 | |
| SCHEMBL7930437 | 0.77 | NOTUM (0.35) | ALDH1A1NOTUMHTT | |
| SCHEMBL7930440 | 0.77 | NOTUM (0.35) | ALDH1A1NOTUMHTT | |
| SCHEMBL8105838 | 0.76 | BCAT1 (0.49) | BCAT1BCAT2SMN1; SMN2ALDH1A1CYP2C9 | |
| SCHEMBL8105836 | 0.76 | BCAT1 (0.49) | BCAT1BCAT2SMN1; SMN2ALDH1A1CYP2C9 | |
| SCHEMBL9423250 | 0.76 | BCAT1 (0.48) | BCAT1BCAT2SMN1; SMN2ALDH1A1CYP2C9 | |
| SCHEMBL10419155 | 0.76 | BCAT1 (0.42) | BCAT1BCAT2SMN1; SMN2ALDH1A1TNF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010031865-A1 | Substituted 3-phenyluracils | KLINTZ RALF (DE) | 2001-10-18 | — | — | US | disclosed |
| US-6239074-B1 | HERBICIDES, INSECTICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2001-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010031865-A1 | Substituted 3-phenyluracils | CCR1, CCR6, CCR3 | BCAT1 139/4885BCAT2 599/4885SMN1; SMN2 4165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.